Drugs
A class action lawsuit has been commenced against Gliatech, Inc. and its senior executives in the United States District Court for the Northern District of Ohio, seeking to recover damages on behalf of defrauded investors who purchased Gliatech securities between April 9, 1998 and August 29, 2000. The complaint alleges
Drugs
Faulding, an international pharmaceutical and health care company, announced that its US-based Purepac oral generic business has received final approval from the FDA to manufacture and market bisoprolol fumerate and hydrochlorothiazide tablets, a generic version of Lederle's Ziac(R) brand tablets. The product is indicated for the treatment
Drugs
Gliatech Inc.'s Board of Directors has announced the receipt of an interim report on the results of its external investigation, which revealed concerns regarding the Company's post-approval U.S. clinical study of ADCON(R)-L. While the investigation is ongoing, the Board has concluded that certain
Drugs
InvestmentHouse.com, a leading Internet-based stock information site, is providing stock split notifications via email to its subscribers, offering a unique service that helps investors stay informed about upcoming stock splits. The company's Stock Split Report, which forecasts stock splits before they are announced, is also available on
Drugs
Genmab A/S, a biotechnology company specializing in developing fully human antibodies to treat various life-threatening and debilitating diseases, has announced plans to seek listings on the Copenhagen and Frankfurt stock exchanges in October 2000. The company, founded in February 1999 through a joint effort between Medarex and Danish investors,
Drugs
The Food and Drug Administration has ordered a warning pamphlet to be attached to each bottle of Lotronex, a drug prescribed for women with irritable bowel syndrome, due to reports of rare but serious side effects. The decision, the first of its kind, came after 15 patients experienced severe side
Drugs
The U.S. Food and Drug Administration (FDA) has approved Tripedia, a diphtheria and tetanus toxoids and acellular pertussis vaccine, for the fifth consecutive dose in the childhood immunization series against diphtheria, tetanus, and pertussis. This approval enables the pediatric healthcare community to use the leading acellular pertussis vaccine for
Drugs
Novartis, Switzerland's biggest drugs company, saw its first-half net profits increase 12% to SFr4.2 billion, driven by higher margins on its core pharmaceuticals business and a surge in net financial income. This suggests that the company is finally distancing itself from local rival Roche, which has traditionally
Drugs
Pharmaceutical giants and research institutions will gather to discuss the latest trends and best practices in outsourcing discovery chemistry and chemical development services at the "Outsourcing Discovery Chemistry & Chemical Development Services" conference in Long Branch, NJ from October 25-27. The event, organized by the Strategic Research Institute,
Drugs
Corixa Corporation and Medicis Pharmaceutical Corporation have entered into a multi-year development, commercialization, and license agreement for Corixa's novel psoriasis immunotherapeutic product, PVAC. Under the agreement, Medicis will have exclusive rights to PVAC treatment in the United States and Canada, while Corixa will be responsible for development and
Drugs
Chiron Corporation, a leading biotechnology company, has entered into a definitive agreement to acquire PathoGenesis Corporation for approximately $700 million. The acquisition positions Chiron as a global player in the treatment and prevention of infectious diseases and cancer. The combined company will have a substantially expanded therapeutic focus in infectious
Drugs
Andrx, a specialty pharmaceutical maker, faces a patent infringement suit from Abbott Labs over its proposed generic version of the anti-epilepsy drug Depakote. Abbott claims that Andrx's proposed generic version violates their patent rights, which were issued in 1991 and 1993. The dispute highlights the common practice of
